Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000502678 | SCV000593010 | likely benign | not specified | 2016-10-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000967299 | SCV001114678 | benign | Dyskeratosis congenita, autosomal dominant 6 | 2023-12-28 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000967299 | SCV002524359 | benign | Dyskeratosis congenita, autosomal dominant 6 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002404308 | SCV002705761 | likely benign | Inborn genetic diseases | 2022-02-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003942619 | SCV004762313 | likely benign | ACD-related disorder | 2022-11-04 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |